PubHawk
N Engl J Med December 2023 PMID 38157500

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.

Simon B Drysdale, Katrina Cathie, Florence Flamein, Markus Knuf, Andrea M Collins, Helen C Hill, Friedrich Kaiser, Robert Cohen, Didier Pinquier, Christian T Felter, Natalya C Vassilouthis, Jing Jin, Mathieu Bangert, Karine Mari, Rapi Nteene

Full text PDF Download social card

Mentions

304
Peak: 80 in Jan 2024
across 5 sources since Dec 2023

Extended reach

1,662,918
potential audience

Total likes

545

Video views

4,574

Mentions per month

Dec 2023 – Dec 2025

Where it's discussed

  • X / Twitter192 posts
  • News94 articles
  • Blogs9 articles
  • YouTube7 videos
  • Facebook2 posts

AI synopsis

What people are saying

The collective discussions celebrate the study’s promising findings, with expressions like 'big step', 'protects infants', and 'so many families will benefit', which highlight optimism about the vaccine's impact. The tone and language convey both excitement and trust in the research, reflecting high engagement and perceived importance.

AgreementStrong agreement

Most discussions strongly support the effectiveness of nirsevimab in preventing RSV hospitalizations, highlighting positive trial results and expert approvals.

InterestHigh interest

Participants show high curiosity and enthusiasm regarding the new data and its potential implications, with many references to the study’s significance.

EngagementHigh engagement

Many posts include detailed acknowledgments of the research, citations of the original NEJM publication, and expressions of pride and hope, indicating deep involvement.

ImpactHigh impact

The overall tone reflects confidence that nirsevimab will significantly influence RSV prevention strategies, with some posts emphasizing its potential to reduce hospital stays and save lives.

Abstract in brief

  • A study was conducted to evaluate the safety and effectiveness of nirsevimab, a monoclonal antibody, in preventing hospitalizations due to respiratory syncytial virus (RSV) in healthy infants during their first RSV season.
  • Infants aged 12 months or younger who were born at least 29 weeks gestation were randomly assigned to receive either nirsevimab or standard care, with results showing that 0.3% in the nirsevimab group were hospitalized compared to 1.5% in the standard-care group, indicating an 83.2% efficacy for nirsevimab.
  • The study also found that severe cases of RSV were less common in the nirsevimab
Read the full abstract

Top posts

Most liked on X and Bluesky
NEJM
@NEJM · X

Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editorial: RSV Prevention — Breakthroughs and Challenges https://t.co/HCkSzAZi7b #IDTwitter https://t.co/NmAY8R9FRe

Dec 30, 2023 · 95 likes · 28 shares · 935,522 followers View post →
SEIP
@seipweb · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 58 likes · 25 shares · 12,403 followers View post →
HSE Covid Consultant
@CovidHse · X

But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%. There is no long-term safety data. Trial published in @nejm & funded by AstraZeneca & Sanofi. Make an informed decision. 2/2 https://t.co/pTyUINu0CY

Jun 18, 2024 · 53 likes · 14 shares · 9,272 followers View post →
Negaman
@Buenrolloreturn · X

Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cachondos. Nirsevimab es Beyfortus, también conocida como la "vacuna de la bronquiolitis", un anticuerpo monoclonal. https://t.co/SEECF7M6V5 https://t.co/JrJyihDQcg

Jan 5, 2024 · 32 likes · 20 shares · 57,885 followers View post →
Negaman
@Buenrolloreturn · X

En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fueron hospitalizados por bronquiolitis. En el grupo placebo fueron hospitalizados 60 por bronquiolitos y no sufrieron efectos adversos. https://t.co/SEECF7M6V5 https://t.co/4j9cDcmgGU

Jan 31, 2024 · 20 likes · 17 shares · 57,885 followers View post →
Christian Pérez
@christianperez · X

✍️ Drysdale SB, Cathie K, Flamein F, et al. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. N Engl J Med. 2023;389(26):2425-2435. doi:10.1056/NEJMoa2309189 https://t.co/pvbrKQnHsp

Jan 28, 2024 · 20 likes · 1 share · 11,715 followers View post →

All mentions

Leonardo M G
@GlzMelendez · X

RT @EBNEO: IAOTY 2024 Two top finalists

Oct 5, 2025 · 4 shares · 85 followers View post →
Rasheda Jasmin Vereen, MD, MBS, FAAP
@Dr_Rasheda · X

RT @EBNEO: IAOTY 2024 Two top finalists

Oct 5, 2025 · 4 shares · 304 followers View post →
Brian King
@BrianKingNeo · X

RT @EBNEO: IAOTY 2024 Two top finalists

Oct 5, 2025 · 4 shares · 2,479 followers View post →
Tapas Kulkarni
@TapasKNeo · X

RT @EBNEO: IAOTY 2024 Two top finalists

Oct 5, 2025 · 4 shares · 350 followers View post →
Evidence-Based Neo
@EBNEO · X

IAOTY 2024 Two top finalists

Oct 5, 2025 · 14 likes · 4 shares · 15,182 followers View post →
Hendrien Meyer
@3nipreeminurse · X

RT @EBNEO: IAOTY 2024 Finalist

Sep 27, 2025 · 2 shares · 305 followers View post →
Fouad Marzouk
@FouadMarzouk78 · X

RT @EBNEO: IAOTY 2024 Finalist

Sep 27, 2025 · 2 shares · 7 followers View post →
Alberto Román
@alberto_roman83 · X

RT @gabizambranoMD: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | New England Journal of Medicine https://t.co/7rcD…

Aug 22, 2025 · 1 share · 2,462 followers View post →
Dra. Gabriela Zambrano
@gabizambranoMD · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | New England Journal of Medicine https://t.co/7rcDhjjVEX

Aug 22, 2025 · 4 likes · 1 share · 2,410 followers View post →
Schwurbeldoktor
@Dr_GackGack · X

@mitodoc @Nadannzeigmal @josef21m @Dr_Peter_Quick @grok @Kessy1972die2 Und noch eine zweite mit ähnlichem Ergebnis. Etwas weniger Hospitalisierungen und ITS in der Impfgruppe, keine Toten in keiner Gruppe, dafür un der Impfgruppe ein Kind mit infantile spasms (West Syndrom). https://t.co/IAWPuPmnuV

May 5, 2025 · 2 likes · 9,832 followers View post →
Christy
@PotFullOfFrogs · X

RT @RetsefL: Links: https://t.co/dkHbxTaQdC https://t.co/AaS37cNyu6 https://t.co/fBcGj70uAN

Mar 4, 2025 · 1 share · 281 followers View post →
Retsef Levi
@RetsefL · X

Links: https://t.co/dkHbxTaQdC https://t.co/AaS37cNyu6 https://t.co/fBcGj70uAN

Mar 4, 2025 · 17 likes · 1 share · 39,450 followers View post →
Leticia Martínez Campos
@LetiMarCam · X

@LactanciaMaM @ClaraOnTheRocks @daandina https://t.co/FgFarSqnEg

Jan 17, 2025 · 1,615 followers View post →
ClaraMC
@ClaraOnTheRocks · X

@LactanciaMaM @daandina https://t.co/JPgi4pzBpw

Jan 16, 2025 · 2 likes · 80 followers View post →
Marcel Proust
@Etruria72 · X

RT @Wondercri1982: https://t.co/xb4tjYDrvh https://t.co/RXStJDqapF

Dec 3, 2024 · 1 share · 7,729 followers View post →
Cristina Wonder
@Wondercri1982 · X

https://t.co/xb4tjYDrvh https://t.co/RXStJDqapF

Dec 3, 2024 · 4 likes · 1 share · 21,173 followers View post →
Vic
@ViK0dine · X

@LefunesteH @Nostra_Damien Du coup je vous laisse lien de l’étude internationale https://t.co/o8TLiRe7Ac franchement, flemme de lire. J’ai une vie en dehors de celle de croire que le gouvernement veut me flinguer.

Nov 24, 2024 · 934 followers View post →
nMeschieri
@NMeschieri · X

@AStramezzi @LaVeritaWeb Cazzata astronomica Lascio - informativa italiana certificata (in foto) - audio originale Harmonie sul NEJM (link) https://t.co/uqkYB8GZ34 che afferma esattamente il contrario Controllate sempre le informazioni https://t.co/gTo7YoG7HL

Nov 3, 2024 · 1 like · 168 followers View post →
Ana
@Ana59896444 · X

@Hyte14192 @DocPepper_FR J'ai bien lu : "The efficacy of nirsevimab against hospitalization for RSV-associated lower respiratory tract infection was 89.6% in France" https://t.co/1btkInzBWv Ou santé publique France : L’efficacité est estimée entre 76%-81% sur la prévention des admissions en réanimation

Sep 17, 2024 · 1 followers View post →
Elaisa Yhuraya
@ElaisaYhu · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jul 10, 2024 · 14 shares · 348 followers View post →
Dr. Paritosh K Kar
@karpk18 · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | New England Journal of Medicine https://t.co/8aU6eSmExB

Jun 30, 2024 View post →
Lainey
@loughlin_elaine · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 19, 2024 · 14 shares · 264 followers View post →
Nelljohn
@HelenThehnote · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 19, 2024 · 14 shares · 232 followers View post →
Oonagh
@Oonagh67696948 · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 19, 2024 · 14 shares · 268 followers View post →
Κεαλαν
@Flyck66 · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 19, 2024 · 14 shares · 4,322 followers View post →
Just Joan (lefty)
@HelenBrundrett · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 19, 2024 · 14 shares · 661 followers View post →
Ellen O’LEARY
@EllenOLEARY18 · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 18, 2024 · 14 shares · 690 followers View post →
Brian Gibney
@gibneyb100 · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 18, 2024 · 14 shares · 1,449 followers View post →
KittytheHare
@Kittythehare654 · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 18, 2024 · 14 shares · 857 followers View post →
Martina
@Martina76597419 · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 18, 2024 · 14 shares · 205 followers View post →
Nydon
@Nydon · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 18, 2024 · 14 shares · 1,602 followers View post →
Nala
@o553400 · X

RT @CovidHse: But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%.…

Jun 18, 2024 · 14 shares · 1,467 followers View post →
HSE Covid Consultant
@CovidHse · X

But actual risk reduction 1.2% for hospitalisation, 0.4% for very severe illness & 0% for death. Actual risk of harm 2.1%. There is no long-term safety data. Trial published in @nejm & funded by AstraZeneca & Sanofi. Make an informed decision. 2/2 https://t.co/pTyUINu0CY

Jun 18, 2024 · 53 likes · 14 shares · 9,272 followers View post →
CoraTheMidwife
@CoralieBorel · X

@Goodflo22 @doctoctocbot en fait pubmed a la réponse : https://t.co/Fjo5e641ZZ

Jun 15, 2024 · 1 like · 1,576 followers View post →
Alasdair Munro
@apsmunro · X

@DrToddLee @alandrummond2 Already done This is case closed - only thing that impacts the decision after this is the price you are able to negotiate https://t.co/HI69Kj2W6i

May 27, 2024 · 53,012 followers View post →
Andrew Tagg
@andrewjtagg · X

RT @DennisRenMD: #SGEMPeds is back with a new episode tomorrow! Dr. @MichaelCosimini joins us to discuss the Harmonie trial. Does nirsevima…

Apr 6, 2024 · 3 shares · 10,566 followers View post →
Western Regional Alliance for Peds Emergency Mgmt
@TheWRAPEM · X

RT @DennisRenMD: #SGEMPeds is back with a new episode tomorrow! Dr. @MichaelCosimini joins us to discuss the Harmonie trial. Does nirsevima…

Apr 5, 2024 · 3 shares · 292 followers View post →
Ken Milne MD
@TheSGEM · X

RT @DennisRenMD: #SGEMPeds is back with a new episode tomorrow! Dr. @MichaelCosimini joins us to discuss the Harmonie trial. Does nirsevima…

Apr 5, 2024 · 3 shares · 28,182 followers View post →
Dennis Ren
@DennisRenMD · X

#SGEMPeds is back with a new episode tomorrow! Dr. @MichaelCosimini joins us to discuss the Harmonie trial. Does nirsevimab affect RSV-associated hospitalizations in infants? #FOAMed #tweetiatrician #PedsTwitter #IDTwitter #MedTwitter @TheSGEM @NEJM https://t.co/0YQXXxO2kn

Apr 5, 2024 · 8 likes · 3 shares · 549 followers View post →
Mugen UJIIE (氏家 無限)
@carpe_diem0820 · X

RT @carpe_diem0820: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants 乳幼児用モノクローナル抗体ニルセビマブは、RSV感染による入院を効果的に予防する。 第3B相試験で…

Mar 8, 2024 · 3 shares · 12,385 followers View post →
Dr. F. Kinder- und Jugendarzt
@kjadrf · X

We are proud that we were part of the Harmonie study group. A big step towards reducing the burden of RSV infections in infants! #rsv #RSV https://t.co/Y3gW04BH5U

Feb 23, 2024 · 3 likes · 403 followers View post →
michele.salata
@SalataMichele · X

RT @medicoebambino: #PaginaGialla: ancora sul #Nirsevimab a tutti Ampio studio “sul campo” che conferma l’efficacia del Nirsevimab non sol…

Feb 17, 2024 · 2 shares · 82 followers View post →
Alessandro Boscarelli, MD, PedSurg, PhD Student
@alexchirped · X

RT @medicoebambino: #PaginaGialla: ancora sul #Nirsevimab a tutti Ampio studio “sul campo” che conferma l’efficacia del Nirsevimab non sol…

Feb 14, 2024 · 2 shares · 147 followers View post →
Medico e Bambino
@medicoebambino · X

#PaginaGialla: ancora sul #Nirsevimab a tutti Ampio studio “sul campo” che conferma l’efficacia del Nirsevimab non solo nel ridurre i ricoveri per #bronchiolite da #RSV ma anche per infezioni basse vie respiratorie da altre cause. https://t.co/nVpfXZHIpQ https://t.co/Q9SEvyAbJZ

Feb 13, 2024 · 2 likes · 2 shares · 665 followers View post →
Dr Mario HMG
@mgmglobal · X

RT @manuelmuro5: Aclaraciones con el artículo original del NEJM sobre la "vacuna" o anticuerpo preventivo de Nirsevimab para la prevención…

Feb 6, 2024 · 2 shares · 2,523 followers View post →
Francisca Martínez
@famartinez2001 · X

RT @manuelmuro5: Aclaraciones con el artículo original del NEJM sobre la "vacuna" o anticuerpo preventivo de Nirsevimab para la prevención…

Feb 4, 2024 · 2 shares · 9,954 followers View post →
Manuel Muro
@manuelmuro5 · X

Aclaraciones con el artículo original del NEJM sobre la "vacuna" o anticuerpo preventivo de Nirsevimab para la prevención de hospitalizaciones por VRS en lactantes. Para @Fernandonsimon https://t.co/ZMRggMi4GU

Feb 4, 2024 · 2 likes · 2 shares · 11,196 followers View post →
elena marcos vox
@abrilenparis · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 3,367 followers View post →
LA VERDAD NOS HARA LIBRES
@RubR80 · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 1,146 followers View post →
BarberoJUSTICIERO.83
@BarberJUSTICIE1 · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 4,783 followers View post →
Plantas Medicinales
@HerbNavigatorES · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 1,316 followers View post →
Bebo lejia, anti
@ea1wg · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 4,247 followers View post →
poto
@poto150672 · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 218 followers View post →
Juan Pico della Mirandola
@juanpicode · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 1,064 followers View post →
Ruth Selena
@RuthMelendrez1 · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 1,451 followers View post →
JCSXXI
@JC_sxxi · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 3,556 followers View post →
Homerton Research & Innovation
@HUH_Research · X

PUBLICATIONS ALERT ‼️ Congratulations to our Neonatal team, who have recently had 3 study articles published that they conducted or participated in. Please find all links below to read the articles. https://t.co/Sk5tMC0rpv https://t.co/iRAfaEMGkT https://t.co/UgVxGjZ1Ee

Jan 31, 2024 · 2 likes · 550 followers View post →
Txykytyna
@txykytyna · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 231 followers View post →
sergio
@SergioFerrerito · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 265 followers View post →
Niklaas
@realNiklaas · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 648 followers View post →
Prueba
@Prueba2222222 · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 1,163 followers View post →
Alejandra Marmolina
@AleMarmolina · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 980 followers View post →
arnelas
@arnelasjmgf · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 808 followers View post →
Madibooo
@madibooo · X

RT @Buenrolloreturn: En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fu…

Jan 31, 2024 · 17 shares · 5,653 followers View post →
Negaman
@Buenrolloreturn · X

En el estudio del enlace: El grupo que recibieron esa "vacuna", 86 niños inoculados tuvieron efectos adversos y 11 fueron hospitalizados por bronquiolitis. En el grupo placebo fueron hospitalizados 60 por bronquiolitos y no sufrieron efectos adversos. https://t.co/SEECF7M6V5 https://t.co/4j9cDcmgGU

Jan 31, 2024 · 20 likes · 17 shares · 57,885 followers View post →
Manolo Tabaiba
@Manolotabaiba1 · X

RT @thefacts_es: ✍️ Drysdale SB, Cathie K, Flamein F, et al. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. N Engl J…

Jan 28, 2024 · 1 share · 812 followers View post →
Christian Pérez
@christianperez · X

✍️ Drysdale SB, Cathie K, Flamein F, et al. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. N Engl J Med. 2023;389(26):2425-2435. doi:10.1056/NEJMoa2309189 https://t.co/pvbrKQnHsp

Jan 28, 2024 · 20 likes · 1 share · 11,715 followers View post →
水城ゆき
@AiloveTh · X

ニルセビマブ、単回投与で済んで重症化の軽減に効果があるのとても素敵 Drysdale SB, Cathie K, Flamein F, et al. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. N Engl J Med. 2023;389(26):2425-2435.

Jan 26, 2024 · 881 followers View post →
Katrina Cathie
@katrinacathie · X

RT @SaulFaust: @SouthamptonBRC @UHSFT https://t.co/0zQcq29fdA

Jan 26, 2024 · 4 shares · 1,012 followers View post →
Carlos Cuevas
@CarlosCucus · X

RT @ndanmontero: El uso de Nirsevimab en bebés demostró efectividad, da lugar a menor gravedad y menos casos de internación relacionada al…

Jan 18, 2024 · 3 shares · 170 followers View post →
Pediatría Pepo
@PediatriaPepo · X

RT @ndanmontero: El uso de Nirsevimab en bebés demostró efectividad, da lugar a menor gravedad y menos casos de internación relacionada al…

Jan 16, 2024 · 3 shares · 269 followers View post →
Juan jose bosch
@juanjbosch · X

RT @ndanmontero: El uso de Nirsevimab en bebés demostró efectividad, da lugar a menor gravedad y menos casos de internación relacionada al…

Jan 16, 2024 · 3 shares · 146 followers View post →
Daniel Montero
@ndanmontero · X

El uso de Nirsevimab en bebés demostró efectividad, da lugar a menor gravedad y menos casos de internación relacionada al virus VSR. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants fue citado por @seipweb https://t.co/86VCybLQXb

Jan 16, 2024 · 9 likes · 3 shares · 4,676 followers View post →
Kyle D.
@KDpharmUS · X

RSV is a leading cause of hospitalization amongst infants. Here are results from a new safety and effectiveness study conducted in a real world setting. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants - PubMed (https://t.co/A4smE1Wa2P)

Jan 8, 2024 · 64 followers View post →
Raising Square Pegs
@RaisingSqrPegs · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/oujyHdbdH6

Jan 7, 2024 · 651 followers View post →
Dr Ramdas Pananthattil
@PananthattilR · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Jan 6, 2024 · 28 shares · 793 followers View post →
Henry Lee
@henryleeneo · X

RT @EBNEO: HARMONIE trial out in @NEJM showed that nirsevimab protected infants against hospitalization for RSV-associated LRTI & against v…

Jan 6, 2024 · 4 shares · 1,125 followers View post →
Ali S.Hussain
@AliSHussain1 · X

RT @EBNEO: HARMONIE trial out in @NEJM showed that nirsevimab protected infants against hospitalization for RSV-associated LRTI & against v…

Jan 6, 2024 · 4 shares · 400 followers View post →
Mina Hanna
@minahhanna · X

RT @Dr_KS_Gautham: This is soon going to become the default approach to prevent RSV hospitalizations. Let's not forget that hand-hygiene is…

Jan 6, 2024 · 2 shares · 170 followers View post →
Brett J. Manley
@drbretty · X

RT @EBNEO: HARMONIE trial out in @NEJM showed that nirsevimab protected infants against hospitalization for RSV-associated LRTI & against v…

Jan 6, 2024 · 4 shares · 4,401 followers View post →
Brian King
@BrianKingNeo · X

RT @EBNEO: HARMONIE trial out in @NEJM showed that nirsevimab protected infants against hospitalization for RSV-associated LRTI & against v…

Jan 6, 2024 · 4 shares · 2,443 followers View post →
Evidence-Based Neo
@EBNEO · X

HARMONIE trial out in @NEJM showed that nirsevimab protected infants against hospitalization for RSV-associated LRTI & against very severe RSV-associated LRTI. Paper: https://t.co/krTYOiV7Aw Editorial: https://t.co/ekCcRmvAnb #EBNEOalerts #neoEBM #neotwitter https://t.co/DxLG81RGeL

Jan 6, 2024 · 12 likes · 4 shares · 15,108 followers View post →
Charlie
@CharlieWings07 · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 773 followers View post →
Carlos Sánchez
@Cyandeceres · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 12,479 followers View post →
Gatalina de Medici
@catstark777 · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 35,058 followers View post →
Freddy G.
@Electromecam · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 596 followers View post →
Dr. K. S. Gautham
@Dr_KSGautham · X

This is soon going to become the default approach to prevent RSV hospitalizations. Let's not forget that hand-hygiene is one of the best ways to prevent RSV infection. #neotwitter Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/9ULI8lvr72

Jan 5, 2024 · 7 likes · 2 shares · 3,516 followers View post →
Leone 02579
@oscar_gm1981 · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 242 followers View post →
liberbrando
@liberbrando · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 1,248 followers View post →
lalita
@Lalita0007 · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 1,905 followers View post →
ayermismo
@ayermismo · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 308 followers View post →
ada #abajoel78
@adaveen4 · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 1,751 followers View post →
Montse Canales Saez
@canales_saez · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 425 followers View post →
euskqwert
@qwertyeusk · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 10,676 followers View post →
imparcialrazon
@imparcialrazon · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 3,848 followers View post →
LA VERDAD NOS HARA LIBRES
@RubR80 · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 1,146 followers View post →
Belonnais
@Belonnais1 · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 1,566 followers View post →
Ana Di Zacco
@Anazacco · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 2,180 followers View post →
jotace&co
@PeeseJotace · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 585 followers View post →
Tragacionistas Out of Context
@discutoynopeleo · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 1,390 followers View post →
Angelisimo
@Angelisimo2 · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 4,475 followers View post →
MANHISP❌
@manhisp · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 891 followers View post →
Cuchita
@Cuchita20692492 · X

RT @Buenrolloreturn: Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cach…

Jan 5, 2024 · 20 shares · 10,919 followers View post →
Negaman
@Buenrolloreturn · X

Este estudio está financiado por las farmacéuticas que lo fabrican. Los que ponen notas de la comunidad son unos cachondos. Nirsevimab es Beyfortus, también conocida como la "vacuna de la bronquiolitis", un anticuerpo monoclonal. https://t.co/SEECF7M6V5 https://t.co/JrJyihDQcg

Jan 5, 2024 · 32 likes · 20 shares · 57,885 followers View post →
KristenThorson
@KThorsonPharmD · X

RSV is a leading cause of hospitalization amongst infants. Here are results from a new safety and efficacy study conducted in a real world setting. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants - PubMed https://t.co/kgzWNWTkMj

Jan 4, 2024 · 1 like · 30 followers View post →
RSVAwareness
@RSVAwareness · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Jan 4, 2024 · 28 shares · 41 followers View post →
Peter Tonsits, PharmD, RPh
@PeterT_PharmD · X

RSV is a leading cause of hospitalization amongst infants. Here are results from a new safety and effectiveness study conducted in a real world setting. https://t.co/cFqFiPJybE

Jan 4, 2024 · 1 like · 34 followers View post →
John (Jack) Crawford, PhD
@johncraw17 · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Jan 4, 2024 · 28 shares · 117 followers View post →
Terianne Wong, PhD, MS
@drTerianneWong · X

RSV remains a leading cause of hospitalization amongst infants. New data was recently published on the safety and effectiveness of the monoclonal antibody Nirsevimab in a real-world setting. https://t.co/7fkwet9FSh

Jan 4, 2024 · 26 followers View post →
Helay Hassas, PharmD
@HelayHassas · X

New data was recently published on the safety and effectiveness of Nirsevimab in a real-world setting. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants - PubMed (https://t.co/zzc71V9xzE)​https://t.co/2HhGQNJxpR

Jan 4, 2024 · 1 like · 56 followers View post →
John (Jack) Crawford, PhD
@johncraw17 · X

New data was recently published on the safety and effectiveness of Nirsevimab in a real-world setting. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants https://t.co/ixGpTuyhEd

Jan 4, 2024 · 3 likes · 117 followers View post →
Alisa Dennis
@AlisaDennis18 · X

New data was recently published on the safety and effectiveness of Nirsevimab in a real-world setting. Nirsevimab for Prevention ofHospitalizations Due to RSV in Infants https://t.co/S2Ce6H5wug PubMed (https://t.co/Uk6fZAxjGo)

Jan 4, 2024 · 4 likes · 37 followers View post →
Kyle D.
@KDpharmUS · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Jan 4, 2024 · 28 shares · 64 followers View post →
Kyle D.
@KDpharmUS · X

New data was recently published on the safety and effectiveness of Nirsevimab in a real-world setting. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants - PubMed (https://t.co/A4smE1VCdh)

Jan 4, 2024 · 1 like · 64 followers View post →
Reem
@findingreemoo · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants https://t.co/B7FLNaYdjd https://t.co/nUTEy45ydN

Jan 4, 2024 · 2 likes · 500 followers View post →
Rodrigo Agüero ⭐⭐⭐
@AgerGastn · X

RT @alfonso_casi: Nirsevimab para la prevención de hospitalizaciones por virus respiratorio sincitial (VRS) en lactantes: Nirsevimab proteg…

Jan 3, 2024 · 1 share · 399 followers View post →
Javier Carrera
@Javier_CarreraH · X

RT @qgorgas: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/d274CHQ3l0

Jan 3, 2024 · 1 share · 1,827 followers View post →
Salud juntos
@alfonso_casi · X

Nirsevimab para la prevención de hospitalizaciones por virus respiratorio sincitial (VRS) en lactantes: Nirsevimab protegió a los bebés contra la hospitalización por infección del tracto respiratorio inferior asociada al VRS y contra... https://t.co/OQmCMG9ybP

Jan 3, 2024 · 1 like · 1 share · 8,586 followers View post →
つ
@tsumicoco1 · X

RT @carpe_diem0820: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants 乳幼児用モノクローナル抗体ニルセビマブは、RSV感染による入院を効果的に予防する。 第3B相試験で…

Jan 3, 2024 · 3 shares · 117 followers View post →
Maria Queralt Gorgas
@qgorgas · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/d274CHQ3l0

Jan 2, 2024 · 2 likes · 1 share · 1,465 followers View post →
Life Science Journal Content
@lsn_jc · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants #science #publication #research #journal https://t.co/OKDxN1hbJh

Jan 2, 2024 · 260 followers View post →
RSV news
@RSVnews · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Jan 2, 2024 · 25 shares · 796 followers View post →
Jens Lundgren
@ProfJLundgren · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. Impressive sample size; endpoints were rare but trends all favoured the active arm. Escape viruses may arise is used extensively. Vaccines are now possible alternatives. https://t.co/mNzkC1NoCM

Jan 2, 2024 · 3 likes · 6,289 followers View post →
Eduardo Zatarain
@EduZatarain · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Jan 2, 2024 · 28 shares · 902 followers View post →
Rubén Silva Ames
@RubnSilvaAmes1 · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Jan 2, 2024 · 25 shares · 60 followers View post →
Louise Sigfrid
@louise_sigfrid · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/3M2HsQ3v8C

Jan 1, 2024 · 1,117 followers View post →
Celia CARDOZO
@CeliaCARDOZO19 · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 31, 2023 · 28 shares · 435 followers View post →
Kelly Schaefer
@KellySchae97400 · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 31, 2023 · 28 shares · 102 followers View post →
Jose Luis Torres
@joseluistc07 · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 31, 2023 · 28 shares · 247 followers View post →
D'Ombre et de Lumière
@louvetou · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 31, 2023 · 28 shares · 132 followers View post →
Oana Sandulescu
@sandulescu_oana · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 31, 2023 · 28 shares · 230 followers View post →
Medicina Intensiva y Emergencias Pediátricas
@MedIntPed · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 30, 2023 · 25 shares · 491 followers View post →
د . احمد سمان
@Ahmed43101178 · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 6,362 followers View post →
Bryson Crushers Fan
@crushergolf · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 824 followers View post →
G剛O　（グラム染色道場主:Gram Stain Gym Instructer）
@ugougoy · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 7,266 followers View post →
Fatima Souza
@__fatimasouza · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 619 followers View post →
Mostapha Habib Allah
@NephroMostapha · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 1,540 followers View post →
IWASHIMA Satoru岩島覚.MD, PhD.ﾔｰ
@SIwa23288585 · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 1,880 followers View post →
Edoardo Melilli
@EdoardoMelilli · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 3,262 followers View post →
Pulm PEEPs
@PulmPEEPs · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 21,339 followers View post →
Martin Correa
@martinrafco · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 231 followers View post →
Ezeonufo Chukwunonso
@Ezeonufo · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 1,372 followers View post →
Simon Drysdale
@sbdrysdale · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 911 followers View post →
Dominique Deplanque
@D_Deplanque · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 836 followers View post →
Andrés Taborro
@MdTaborro · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 450 followers View post →
Joshua Kimbrell
@joshkimbre · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 1,613 followers View post →
Michael O'Byrne
@obyrne_md · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 430 followers View post →
KanzakiS
@nchdaks · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 674 followers View post →
Franpe
@franpe_k · X

RT @NEJM: Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editor…

Dec 30, 2023 · 28 shares · 137 followers View post →
NEJM
@NEJM · X

Original Article: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (HARMONIE) https://t.co/nau4oijLaC Editorial: RSV Prevention — Breakthroughs and Challenges https://t.co/HCkSzAZi7b #IDTwitter https://t.co/NmAY8R9FRe

Dec 30, 2023 · 95 likes · 28 shares · 935,522 followers View post →
Joyce K. Andrade Velásquez
@joyceandradev · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 30, 2023 · 25 shares · 262 followers View post →
Jose Maria Saenz Lastari
@Arthur_pediatra · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 30, 2023 · 25 shares · 104 followers View post →
Paco Ferouelle
@PacoFerouelle · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 30, 2023 · 25 shares · 84 followers View post →
Guía-ABE
@Guia_ABE · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 30, 2023 · 25 shares · 8,389 followers View post →
Iván Carabaño
@ivancarab · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 30, 2023 · 25 shares · 3,579 followers View post →
Congreso AEPAp
@CongresoAEPap · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 29, 2023 · 25 shares · 86 followers View post →
Javier Benito
@JavierBenitoF · X

RT @MintegiSanti: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/zNa3AFHc7C

Dec 29, 2023 · 7 shares · 772 followers View post →
María Domínguez
@mdvcarrick · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 29, 2023 · 25 shares · 117 followers View post →
Pedro A. Bailón de la O.
@DrPedroBO · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 29, 2023 · 25 shares · 222 followers View post →
Javier Prego Petit
@Javier_Prego · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 29, 2023 · 25 shares · 3,526 followers View post →
Abstream
@abstreamme · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants #science #publication #research #publications https://t.co/fQUzUWSDKN

Dec 29, 2023 · 785 followers View post →
David Castillo
@davidca2708 · X

RT @ndanmontero: El uso de Nirsevimab en bebés demostró efectividad, da lugar a menor gravedad y menos casos de internación relacionada al…

Dec 29, 2023 · 1 share · 202 followers View post →
Daniel Montero
@ndanmontero · X

El uso de Nirsevimab en bebés demostró efectividad, da lugar a menor gravedad y menos casos de internación relacionada al virus VSR. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants fue citado por @seipweb https://t.co/86VCybLQXb

Dec 29, 2023 · 6 likes · 1 share · 4,676 followers View post →
Paola
@palpinzon · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM. Nirsevimab protected infants against hospitalization for RSV-associated lower respiratory tract infection and against very severe RSV-associated lower respiratory tract infection. https://t.co/sCTYShMVON

Dec 29, 2023 · 1 like · 233 followers View post →
Jorge Pleitez Navarrete MD
@Pleitez1970 · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 29, 2023 · 25 shares · 1,309 followers View post →
Cristina Calvo
@CcalvoreyRITIP · X

RT @fedemartinon: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/1zFzzvaWZY Congrats @sbdrysdale a…

Dec 29, 2023 · 4 shares · 898 followers View post →
César David Hernández Rosales
@drdavidhdez · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 449 followers View post →
Jose Tascon Arcila
@JoseATascon · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM ⁦@TheBCRP⁩ https://t.co/JiKDL7uTxG

Dec 28, 2023 · 5 likes · 653 followers View post →
Camilo Rincon Millan
@xmilocox88 · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 196 followers View post →
煩悩寺の矛盾した人
@m4Nrc1Pz7iSs5VG · X

RT @carpe_diem0820: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants 乳幼児用モノクローナル抗体ニルセビマブは、RSV感染による入院を効果的に予防する。 第3B相試験で…

Dec 28, 2023 · 3 shares · 295 followers View post →
Mugen UJIIE (氏家 無限)
@carpe_diem0820 · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants 乳幼児用モノクローナル抗体ニルセビマブは、RSV感染による入院を効果的に予防する。 第3B相試験では、乳幼児の重症RSV関連呼吸器感染症の予防に83.2％の有効性を示した。 https://t.co/uspzdcVE3A https://t.co/OlcRI20Osp

Dec 28, 2023 · 11 likes · 3 shares · 12,385 followers View post →
Daniela Orozco Acosta
@DanielaOR · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 320 followers View post →
Oscarleo
@27Oscarleo · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 566 followers View post →
Alejandra Merino
@amerinopardo · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 94 followers View post →
Ana Díez
@analudiezrec · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 37 followers View post →
Katrina Cathie
@katrinacathie · X

RT @fedemartinon: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/1zFzzvaWZY Congrats @sbdrysdale a…

Dec 28, 2023 · 4 shares · 1,012 followers View post →
Cristóbal Buñuel
@Pediatria · X

RT @MintegiSanti: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/zNa3AFHc7C

Dec 28, 2023 · 7 shares · 13,066 followers View post →
john morley
@drjohnmorley · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/1U43TTlPv4

Dec 28, 2023 · 8,325 followers View post →
Servicio de Farmacia HULP
@FarmaciaLaPlana · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 410 followers View post →
Julia Bodega Azuara
@JuliaBodega · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 322 followers View post →
Paul Dark
@DarkNatter · X

RT @ResearchSolomon: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM Congratulations @SaulFaust, Simon Royal and…

Dec 28, 2023 · 1 share · 2,727 followers View post →
Julie Solomon
@ResearchSolomon · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM Congratulations @SaulFaust, Simon Royal and colleagues on the clear outcome of this trial. So many families will be able to benefit from better health. https://t.co/Kz1KJWYatp @PhilEvansCRN @DarkNatter

Dec 28, 2023 · 4 likes · 1 share · 684 followers View post →
Academia VRS - RSV Academy
@academiavrs · X

RT @fedemartinon: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/1zFzzvaWZY Congrats @sbdrysdale a…

Dec 28, 2023 · 4 shares · 148 followers View post →
Javier Prego Petit
@Javier_Prego · X

RT @MintegiSanti: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/zNa3AFHc7C

Dec 28, 2023 · 7 shares · 3,526 followers View post →
Actualfarma
@Actualfarma1 · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 553 followers View post →
Madhu Gangadhara
@madhubg309 · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/EKRZ4LPS6Q

Dec 28, 2023 · 3 likes · 376 followers View post →
José-Lorenzo Bravo,MD, PhD
@jlorenzobravo · X

RT @fedemartinon: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/1zFzzvaWZY Congrats @sbdrysdale a…

Dec 28, 2023 · 4 shares · 306 followers View post →
Federico Martinón-Torres
@fedemartinon · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/1zFzzvaWZY Congrats @sbdrysdale and team!!

Dec 28, 2023 · 15 likes · 4 shares · 10,898 followers View post →
María Moral
@twittmariamoral · X

RT @seipweb: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 25 shares · 855 followers View post →
SEIP
@seipweb · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/81ECosYzxO https://t.co/NQIZvRUCtV

Dec 28, 2023 · 58 likes · 25 shares · 12,403 followers View post →
Isaura R. Penin
@irodriguezpenin · X

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/ltDLsjgiCq

Dec 28, 2023 · 622 followers View post →
Michael Barrett
@DrMBarrett · X

RT @MintegiSanti: Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM https://t.co/zNa3AFHc7C

Dec 28, 2023 · 7 shares · 1,141 followers View post →